Ebola Vaccine Approved for Use in Europe
Ebola Vaccine Approved for Use in Europe
Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.
Ebola Vaccine Approved for Use in Europe
Ebola Vaccine Approved for Use in Europe

Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.

Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.

vaccination
Measles Leaves the Immune System Vulnerable to Other Diseases
Measles Leaves the Immune System Vulnerable to Other Diseases
Ruth Williams | Oct 31, 2019
Two studies present biological evidence that measles infections in unvaccinated children wipe out immune memories of other pathogens, putting the kids at risk of other deadly diseases.
More Evidence that Enterovirus May Cause Kids’ Paralyzing Disease
More Evidence that Enterovirus May Cause Kids’ Paralyzing Disease
Catherine Offord | Oct 22, 2019
Children with acute flaccid myelitis are more likely to have antibodies against the viral family in their spinal fluid than are children without the illness.
Laskers Go to Immunologists, Developers of Breast Cancer Therapy
Laskers Go to Immunologists, Developers of Breast Cancer Therapy
Jef Akst | Sep 10, 2019
The 2019 Lasker medical and research awards celebrate advances in scientists’ understanding of T and B cells, Herceptin antibodies for treating breast cancer, and vaccine coverage around the globe.
Gut Microbes Boost Flu Vaccine’s Success: Clinical Trial
Gut Microbes Boost Flu Vaccine’s Success: Clinical Trial
Abby Olena | Sep 5, 2019
Antibiotics disrupt the immune response to the influenza vaccine in people who haven’t recently had exposure to the virus or immunization.
Europe Had 90,000 Measles Cases in First Half of 2019
Europe Had 90,000 Measles Cases in First Half of 2019
Chia-Yi Hou | Aug 30, 2019
The number of measles cases this year is already more than all of the cases reported in 2018.
Vaccine Exemptions May Allow for Large Measles Outbreaks
Vaccine Exemptions May Allow for Large Measles Outbreaks
Abby Olena | Aug 21, 2019
Mathematical models reveal that current vaccination rates in Texas schools could pave the way for the virus to spread to hundreds of people.
Personalized Cancer Vaccines in Clinical Trials
Personalized Cancer Vaccines in Clinical Trials
Jasreet Hundal, Elaine R. Mardis | Jul 15, 2019
The field is young, but predicting antigens produced by patients’ malignant cells could yield successful treatments for individuals with a range of cancer types.
Study Finds Low Trust in Vaccines in Europe
Study Finds Low Trust in Vaccines in Europe
Chia-Yi Hou | Jun 19, 2019
Just half of respondents in Eastern Europe agree that vaccines are safe.
Belief in the Unseen
Belief in the Unseen
Bob Grant | Jun 1, 2019
Science doesn’t require faith, but fostering trust in its practitioners can help the public move past unfounded doubts.